Orfiril Long (Sodium Valproate)

Sodium Valproate, the active ingredient in Orfiril Long, is an anticonvulsant presented as a oral formulation for oral use. It treats generalized tonic‑clonic seizures, absence seizures, myoclonic seizures, bipolar disorder and migraine prophylaxis in patients requiring long‑term seizure control. GNH USA supplies Orfiril Long as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orfiril Long as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orfiril Long is an antiepileptic drug that controls abnormal ​     ​  ​      ​  ​  ​  ​  ​    ​  ​  ​        ​ ​  ​        ​ ​          ​ ​ ​    ​

- Generalized tonic‑clonic seizures: Reduces the frequency and severity  ​​  ​  ​  ​ - Absence seizures: Decreases the number ​ ​  ​ - Myoclient ​  ​  ​  ... ... ... ...  …  … … … … … … … …